As of June 03, 2025, Taysha Gene Therapies (TSHA) has a market cap of $0.73 billion USD. According to our data, Taysha Gene Therapies is ranked No.5598 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $0.73 B |
60.69%
|
Dec 31, 2024 | $0.45 B |
-2.26%
|
Dec 29, 2023 | $0.46 B |
-21.68%
|
Dec 30, 2022 | $0.59 B |
-80.60%
|
Dec 31, 2021 | $3.05 B |
-56.10%
|
Dec 31, 2020 | $6.94 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$3.82 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.51 B |
0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.83 B |
0.000 M
|
![]() Netherlands
|
![]() Adverum Biotechnologies
ADVM
|
$52.44 M |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$48.67 M |
0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.27 B |
0.000 M
|
![]() USA
|
![]() MeiraGTx
MGTX
|
$0.45 B |
0.000 M
|
![]() USA
|
![]() Passage Bio
PASG
|
$28.59 M |
0.000 M
|
![]() USA
|
![]() Generation Bio
GBIO
|
$26.73 M |
0.000 M
|
![]() USA
|
Market Cap | = | TSHA Stock Price | * | TSHA Shares Outstanding |
= | $2.78 | * | 0.26 B | |
= | $0.73 B |